Questionnaire Survey on the User Experience of Sulprep and Niflec for Colonoscopy Preparatio
- Conditions
- Colonoscopy
- Registration Number
- JPRN-UMIN000053527
- Lead Sponsor
- Sendai city medical center Sendai open hospital, department of Gastroenteology, Yuta Shibuya.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Not provided
Exclude individuals who meet any of the following criteria Individuals with evident taste disorders. Individuals who have difficulty responding to questionnaires. Individuals with uncertain or unknown intake of laxatives or fluids, or those where uncertainty is anticipated. Individuals with allergies to the ingredients of Sulprep, Nifrec, or sodium picosulfate. Individuals unable to take the recommended dose of Sulprep. Individuals with lesions requiring procedures such as endoscopic submucosal dissection rather than typical polypectomy or mucosal resection. Patients with end-stage renal failure or undergoing dialysis. Patients in whom the cecum or anastomosis could not be reached during TCS. Patients in whom serious conditions such as advanced cancer were identified during TCS, aside from polyps suitable for removal. Patients who experienced serious adverse events during TCS. Patients with severe constipation planning to use methods other than the standard pre-procedural measures. Individuals deemed inappropriate by the attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The burden of pre-procedural preparation with Suprep compared to Niflec in surveys.
- Secondary Outcome Measures
Name Time Method Ease of ingestion of the laxative, efficacy in bowel cleansing, volume of laxative and water intake, adverse events, etc., comparing Suprep and Niflec in surveys.